Showing results (1671-1680 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|May 28, 2013
Do we need to consider ethno-cultural variation in the use of atypical antipsychotics for Asian patients with major depressive disorder?Changsu Han, Chi-Un PaeCNS Drugs|May 18, 2013
Blocking LINGO-1 as a therapy to promote CNS repair: from concept to the clinicSha Mi, R Blake Pepinsky, Diego CadavidCNS Drugs|June 27, 2013
Safety, tolerability, and efficacy of oral therapies for relapsing-remitting multiple sclerosisJiwon Oh, Paul W O'ConnorCNS Drugs|January 30, 2013
Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders. Rationale for development and current statusMichihiro Mieda, Takeshi SakuraiCNS Drugs|January 23, 2013
Galanthamine in Alzheimer's disease : a new alternative to tacrine?M RainerCNS Drugs|January 23, 2013
Subacute sclerosing panencephalitis : diagnosis and drug treatment optionsB AnlarCNS Drugs|January 23, 2013
Mechanism of clozapine-induced agranulocytosis : current status of research and implications for drug developmentM Pirmohamed, K ParkCNS Drugs|January 23, 2013
Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorderR H Foster, K L GoaCNS Drugs|January 25, 2013
Newly initiated opioid treatment and the risk of fall-related injuries. A nationwide, register-based, case-crossover study in SwedenKarin C Söderberg, Lucie Laflamme, Jette MöllerPageof 211